OST Group becomes a shareholder in July 2019 – MessengerBiopharma

Our mRNA Platform
- Aegis
- Nuntius
- Mathusalem
- Fastigium
Our Business Model
- Partnership
- Out-licensing
About Us
Contact Us
News

Our mRNA Platform
- Aegis
- Nuntius
- Mathusalem
- Fastigium
Our Business Model
- Partnership
- Out-licensing
About Us
Contact Us
News

OST Group becomes a shareholder in July 2019

photo animalerie 1

posted Jul 08 2019

Messenger Biopharma

Messenger Biopharma has perfected a messenger RNA biotechnology platform to treat and prevent numerous diseases.

News

Messenger Biopharma launches the commercialization of its Nuntius biotechnology

October 10, 2024

OST Group becomes a shareholder in July 2019

July 08, 2019

Address

22 rue Henri et Gilberte Goudier
F-63200 Riom
+33 637 737 702

Partners

List of partners

©copyright 2016 Coqpit

Home
Aegis™ Biotechnology
Nuntius
Mathusalem
Partnership
Out-licensing
Contact Us
About Us

Recent Search Keywords